Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.

Cong XiaJin-Rong QuYi-Ping JiaoChun-Qiang LuBen ZhaoRong-Jun GeYue QiuBu-Yue CaoQian YuTian-Yi XiaXiang-Pan MengYang SongLi-Hua ZhangXue-Ying LongJing YeZhi-Min DingWu CaiSheng-Hong Ju

Published in: European radiology (2024)

Imaging biomarkers are needed to better characterize tumor tissue in pancreatic adenocarcinoma. Signal enhancement ratio (SER)-predicted stromal/epithelial proportion showed good agreement with histopathology measurements across three distinct centers. Signal enhancement ratio (SER)-predicted stromal proportion was demonstrated to be an independent prognostic factor for OS in PDAC.

Keyphrases

contrast enhanced
magnetic resonance imaging
prognostic factors
diffusion weighted
magnetic resonance
high resolution
computed tomography
diffusion weighted imaging
bone marrow
dual energy